JP2009529048A - 経口インターフェロンによる広域免疫および抗ウイルス遺伝子調節 - Google Patents
経口インターフェロンによる広域免疫および抗ウイルス遺伝子調節 Download PDFInfo
- Publication number
- JP2009529048A JP2009529048A JP2008558342A JP2008558342A JP2009529048A JP 2009529048 A JP2009529048 A JP 2009529048A JP 2008558342 A JP2008558342 A JP 2008558342A JP 2008558342 A JP2008558342 A JP 2008558342A JP 2009529048 A JP2009529048 A JP 2009529048A
- Authority
- JP
- Japan
- Prior art keywords
- interferon
- alferon
- human
- animal
- antiviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Abstract
Description
本出願は2006年3月8日に出願された米国仮特許出願番号第60/80,079号に基づく優先権を主張する。
体内への投与の場合、α‐インターフェロンは、たとえば慣用の方法で経口、鼻腔内または口腔内投与のために製剤されてもよい。経口投与のための製剤には、水性溶液、シロップ、エリキシル、粉末剤、顆粒剤、錠剤およびカプセル剤が挙げられ、それらは典型的には慣用の賦形剤、たとえば結合剤、充填剤、潤沢剤、崩壊剤、湿潤剤、懸濁化剤、乳化剤、保存剤、バッファー塩、香味剤、着色および/または甘味剤が挙げられる。
カニクイサル(Macaca fascicularis)はインフルエンザウイルスH5N1に感染させ、マカクにおける臨床徴候はトリインフルエンザH5N1ウイルスに感染したヒトに見いだされる徴候に類似することが証明されているので、従ってインフルエンザH5N1ウイルスによるカニクイサルの感染はヒトにおけるこれらの感染のモデルとして役立つ(Rimmelzwaan et al.Avian Dis.2003;47(3 Suppl):931−3,Kuiken et al.Vet Pathol.2003 May;40(3):304−10,Rimmelzwaan et al.Virol.2001 Jul;75(14):6687−91)。
アレイ構築 この研究で使用されるアレイはReserach Genetics Inc.の配列が証明されたcDNAクローンのサブセットを含み、アデニレート/ウリジレートリッチエレメントを含む950遺伝子およびAU−指向mRNA減少に潜在的に関与する18遺伝子を表す、40,000クローンセット、多様な細胞型においてIFNによって刺激される、確認された候補遺伝子を含む、先に記載のクローンセットの拡張を表す855ISG、ウイルスアナログポリ(I).ポリ(C)に反応する288遺伝子、および85ハウスキーピング遺伝子。
Claims (6)
- 感染した動物またはヒトにアルファインターフェロンを経口投与することを含む、ヒトを含む動物において抗ウイルス/免疫調節反応を誘発する方法。
- 動物またはヒトにアルファインターフェロンを経口投与することを含む、生得免疫反応を全身的に活性化する方法。
- インターフェロンが動物の体重1ポンドにつき少なくとも3IUの量で、経口的に、または鼻腔内投与される、請求項1または2に記載の方法。
- ウイルスへの暴露前、またはウイルスへの暴露直後であるが症状を示す前に、動物またはヒトにアルファインターフェロンを経口投与することを含む、感受性の高いウイルス感染の作用を緩和するか、またはそれに対して抵抗性を与える、方法。
- インターフェロンが動物の体重1ポンドにつき少なくとも3IUの量で、経口的に、または鼻腔内投与される、請求項4に記載の方法。
- ウイルス感染がトリインフルエンザである、請求項4に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78007906P | 2006-03-08 | 2006-03-08 | |
US11/713,097 US8075877B2 (en) | 2006-03-08 | 2007-03-02 | Broad spectrum immune and antiviral gene modulation by oral interferon |
PCT/US2007/005634 WO2008054464A2 (en) | 2006-03-08 | 2007-03-06 | Broad spectrum immune and antiviral gene modulation by oral interferon |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009529048A true JP2009529048A (ja) | 2009-08-13 |
Family
ID=39344776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008558342A Pending JP2009529048A (ja) | 2006-03-08 | 2007-03-06 | 経口インターフェロンによる広域免疫および抗ウイルス遺伝子調節 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8075877B2 (ja) |
EP (1) | EP1991254A4 (ja) |
JP (1) | JP2009529048A (ja) |
AU (1) | AU2007314649B2 (ja) |
WO (1) | WO2008054464A2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005009337A2 (en) * | 2003-05-16 | 2005-02-03 | Hemispherx Biopharma | Treating severe acute respiratory syndrome |
US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
US8075877B2 (en) | 2006-03-08 | 2011-12-13 | Hemispherx Biopharma | Broad spectrum immune and antiviral gene modulation by oral interferon |
CN101437534A (zh) * | 2006-03-08 | 2009-05-20 | 半球生物制药公司 | 口服干扰素的广谱免疫和抗病毒基因调节作用 |
WO2015027056A1 (en) | 2013-08-21 | 2015-02-26 | Hemispherx Biopharma, Inc. | NOVEL METHOD OF REDUCING ANTIGENIC DRIFT OR REASSORTMENT OF VIRUSES IN A HOST ANIMAL USING α- INTERFERON |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910304A (en) * | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
WO2005009337A2 (en) * | 2003-05-16 | 2005-02-03 | Hemispherx Biopharma | Treating severe acute respiratory syndrome |
JP2005089301A (ja) * | 2003-09-12 | 2005-04-07 | Hayashibara Biochem Lab Inc | ウシの消化器疾患治療剤 |
US20060024271A1 (en) * | 2004-01-15 | 2006-02-02 | Ken Alibek | Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination |
US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
WO2006082435A1 (en) * | 2005-02-04 | 2006-08-10 | Viranative Ab | Method and use of interferon compositions for the treatment of avian influenza |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1320905C (en) | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
ZA878295B (en) * | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
US4950652A (en) | 1987-03-23 | 1990-08-21 | Hem Research, Inc. | dsRNAs for combination therapy in the treatment of viral diseases |
TW589189B (en) | 1997-08-04 | 2004-06-01 | Scras | Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis |
AU2003263978A1 (en) | 2002-08-01 | 2004-02-23 | Board Of Trustees Of The Leland Stanford Junior University | 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections |
JP2006528679A (ja) | 2003-04-01 | 2006-12-21 | インターミューン インコーポレイテッド | コロナウイルス感染症及びサースを治療するための組成物及び方法 |
US20070270360A1 (en) | 2003-04-15 | 2007-11-22 | Sirna Therapeutics, Inc. | Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid |
EP1618189A4 (en) | 2003-04-25 | 2007-07-18 | Intradigm Corp | ARNI AGENTS FOR ANTI-CORONAVIRUS SARS THERAPY |
US7339051B2 (en) | 2003-04-28 | 2008-03-04 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
CN101437534A (zh) | 2006-03-08 | 2009-05-20 | 半球生物制药公司 | 口服干扰素的广谱免疫和抗病毒基因调节作用 |
US8075877B2 (en) | 2006-03-08 | 2011-12-13 | Hemispherx Biopharma | Broad spectrum immune and antiviral gene modulation by oral interferon |
-
2007
- 2007-03-02 US US11/713,097 patent/US8075877B2/en active Active
- 2007-03-06 AU AU2007314649A patent/AU2007314649B2/en active Active
- 2007-03-06 WO PCT/US2007/005634 patent/WO2008054464A2/en active Application Filing
- 2007-03-06 EP EP07867004A patent/EP1991254A4/en not_active Withdrawn
- 2007-03-06 JP JP2008558342A patent/JP2009529048A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910304A (en) * | 1982-12-13 | 1999-06-08 | Texas A&M University System | Low-dose oral administration of interferons |
WO2005009337A2 (en) * | 2003-05-16 | 2005-02-03 | Hemispherx Biopharma | Treating severe acute respiratory syndrome |
US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
JP2005089301A (ja) * | 2003-09-12 | 2005-04-07 | Hayashibara Biochem Lab Inc | ウシの消化器疾患治療剤 |
US20060024271A1 (en) * | 2004-01-15 | 2006-02-02 | Ken Alibek | Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination |
WO2006082435A1 (en) * | 2005-02-04 | 2006-08-10 | Viranative Ab | Method and use of interferon compositions for the treatment of avian influenza |
Also Published As
Publication number | Publication date |
---|---|
EP1991254A4 (en) | 2009-11-11 |
AU2007314649B2 (en) | 2013-08-29 |
EP1991254A2 (en) | 2008-11-19 |
US8075877B2 (en) | 2011-12-13 |
AU2007314649A1 (en) | 2008-05-08 |
WO2008054464A2 (en) | 2008-05-08 |
US20090004141A1 (en) | 2009-01-01 |
WO2008054464A3 (en) | 2008-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5539363B2 (ja) | インターフェロンおよびリバビリンとのhcvns3プロテアーゼ阻害剤の組合せ | |
JP5209180B2 (ja) | トリインフルエンザ感染の治療 | |
HUT72965A (en) | Therapeutic combination containing interferon | |
JP2009529048A (ja) | 経口インターフェロンによる広域免疫および抗ウイルス遺伝子調節 | |
US7678774B2 (en) | Treating severe acute respiratory syndrome | |
KR20120106942A (ko) | Bi201335, 인터페론 알파 및 리바비린을 포함하는 hcv 병용 치료요법을 위한 투여 용법 | |
US8075878B2 (en) | Broad spectrum immune and antiviral gene modulation by oral interferon | |
Hou et al. | Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia | |
JP2003507339A (ja) | PEG−IFN−αと共同させたミコフェノラートモフェチル | |
AU2009215129B2 (en) | Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species | |
US9084758B2 (en) | Antiviral compositions comprising ethanol extract of Tetracera scandens and use thereof | |
Pluta et al. | The use of interferon in medicine | |
JPH07188052A (ja) | インターフェロン用作用効果増強剤及び該増強剤とインターフェロンとを含有する抗ウイルス活性増強組成物 | |
AU746648B2 (en) | Use of IFN-alpha and amantadine for the treatment of chronic hepatitis C | |
CN112691094B (zh) | 防治病毒的新型化合物及其应用 | |
WO2004083186A1 (ja) | ウイルス性肝炎治療剤及び制癌剤 | |
US11642396B2 (en) | Method of reducing antigenic drift or reassortment of viruses in a host animal using α interferon | |
CN116251114A (zh) | 龙胆苦苷在制备防控病毒或细菌感染的药物中的应用 | |
CN116870134A (zh) | θ-防御素在制备抗猫杯状病毒感染药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100305 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120413 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120713 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120725 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120727 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121101 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130131 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130220 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130228 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130328 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130329 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130412 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130501 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130624 |